Elena Rybakina slams WTA probe into Vukov as Australian Open nears – video
Sudan’s army recaptures Wad Madani from rebel Rapid Support Forces
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Bizarre Australian mole even more unusual than first thought, new research reveals
Memo to Trump: US telecoms is vulnerable to hackers. Please hang up and try again | John Naughton
Britain’s biggest drugmaker acquires Seattle-based firm Icosavax, expanding vaccine and immune therapy business
AstraZeneca is buying its first vaccine company in a $1.1bn deal that will expand the vaccine and immune therapy business it set up during the Covid pandemic.
Britain’s biggest drugmaker has agreed to take over the Seattle-based company Icosavax, which is developing a potential vaccine for two common respiratory diseases.
More Stories
Bizarre Australian mole even more unusual than first thought, new research reveals
Male mosquitoes to be genetically engineered to poison females with semen in Australian research
Breakthrough drugs herald ‘new era’ in battle against dementia, experts predict